Cargando…
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma
BACKGROUND: Better treatments for glioblastoma (GBM) patients, in particular in the recurrent setting, are urgently needed. Clinical trials performed in Brazil indicated that intranasal delivery of perillyl alcohol (POH) might be effective in this patient group. NEO100, a highly purified version of...
Autores principales: | Schönthal, Axel H, Peereboom, David M, Wagle, Naveed, Lai, Rose, Mathew, Anna J, Hurth, Kyle M, Simmon, Vincent F, Howard, Steven P, Taylor, Lynne P, Chow, Frances, da Fonseca, Clovis O, Chen, Thomas C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879254/ https://www.ncbi.nlm.nih.gov/pubmed/33604574 http://dx.doi.org/10.1093/noajnl/vdab005 |
Ejemplares similares
-
Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case
por: Schönthal, Axel H., et al.
Publicado: (2022) -
Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
por: Chen, Thomas C., et al.
Publicado: (2018) -
Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy
por: Santos, Juliana Guimaraes, et al.
Publicado: (2020) -
The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers
por: Chen, Thomas C., et al.
Publicado: (2021) -
Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice
por: Cho, Hee-Yeon, et al.
Publicado: (2020)